Newsletter
The Real Chemistry Podcast

The Real Chemistry Podcast

The Real Chemistry podcast connects the dots between our guests and the innovative work they do to show up and shape the future of healthcare.

Valuing Empathy to Ensure Patient-Centered Healthcare Strategies: Javeria Shahab, 21GRAMS, a part of Real Chemistry

In this episode, Javeria Shahab, President of Medical Education at 21GRAMS, a part of Real Chemistry, discusses the challenges and changes in the medical education industry, building effective teams and the importance of empathy in healthcare communications. Get an insider's look into the industry and hear Javeria's advice for those looking to break into the field.
September 14, 2023

Informing Public Health Decisions with Data and Science: Sue Desmond-Hellmann, M.D., Council of Advisors on Science and Technology

In this episode, Dr. Sue Desmond-Hellmann, Member of President Biden’s Council of Advisors on Science and Technology and former CEO of the Bill & Melinda Gates Foundation, Mike Huckman, Global Practice Leader of Executive Communications at Real Chemistry, and Jim Weiss, Founder and Chairman at Real Chemistry, discuss the importance of vaccination, the evolution of cancer treatments and the challenges of clinical trials. They also highlight the need for diverse representation in clinical trials, the implications of the Inflation Reduction Act on the pharmaceutical industry and the influence of science in public health and policymaking.
September 7, 2023

Pioneering Public-Private Partnerships to Tackle Complex Health Issues: Dr. Julie Gerberding, FNIH, Dr. Jay Bradner, FNIH & Jim Weiss, Real Chemistry

In this episode, Dr. Julie Gerberding, President and CEO of the Foundation for the National Institutes of Health (FNIH), Dr. Jay Bradner, FNIH board member and former President of the Novartis Institutes for Biomedical Research, and Jim Weiss, Founder and Chairman at Real Chemistry and FNIH board member, discuss the power of collaboration, how trust in science is essential for progress, emerging areas in medicine and the challenges of the current healthcare landscape. Listen to the full episode to gain valuable insights and to learn how FNIH is pioneering public-private partnerships to tackle complex health issues.
July 20, 2023

Analyzing the Impact of Data and Technology on Healthcare Commercialization: Mark Martin, Houlihan Lokey & Jim Weiss, Real Chemistry

In this episode, Mark Martin, Managing Director at Houlihan Lokey, and Jim Weiss, Founder and Chairman at Real Chemistry, explore the healthcare marketing and commercialization industry, including the impact of data and technology, trends in acquisitions and deals, and the importance of organic growth and innovation.
June 22, 2023

Developing Innovative Digital Medicine Solutions that Address Real Pain Points: Jennifer Goldsack, Digital Medicine Society

Digital medicine is essential for improving healthcare and addressing issues related to access and equity. In the latest episode, learn about the importance of digital medicine, the challenges and opportunities in the industry and the importance of an integrated evidence plan. Plus, CEO and Co-Founder of the Digital Medicine Society (DiMe), Jennifer Goldsack, shares her thoughts on generative AI and advice for young professionals in healthcare. As part of DiMe’s upcoming Integrated Evidence Plans for Digital Health Products (IEP) project, leaders in digital health product development, regulation, reimbursement and commercial strategy will partner with payers, purchasers, policymakers, clinicians and patient groups to identify core components of an integrated evidence plan. If you would like to engage in this project and help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients, learn more and share your interest to join (https://dimesociety.org/access-resources/evidence-defined/#iep-form).
June 15, 2023

Addressing Liver Health through Collaboration and Innovation: Donna Cryer, Global Liver Institute

Did you know that there are more than 100 types of liver diseases that affect 1.5 billion people worldwide? Join us as we explore the importance of collaboration and innovation in addressing liver health issues, the role of digital health and equity, and the future of liver health with Donna Cryer, J.D., Founder, President and CEO of the Global Liver Institute. Get the inside scoop on the latest developments in the field of liver health and how they can improve patient outcomes and access to care.
June 8, 2023
View All Episodes

The Real Chemistry Podcast

The Real Chemistry podcast connects the dots between our guests and the innovative work they do to show up and shape the future of healthcare. Why? So, you, the listener, are encouraged to join us in our relentless pursuit to make the world a healthier place for all. Some may call it idealism. We call it Real Chemistry.

Host

Aaron Strout

Aaron Strout

Aaron is the CMO of Real Chemistry (formerly W2O Group), a global health innovation company committed to making the world a healthier place for all. He is a seasoned, strategic marketer who grew up in digital. During his 25+ years in the industry, he has been a pioneer in mobile and location-based marketing. Throughout his career, he has focused on client success, building high-performance teams and profitable revenue growth. Prior to joining W2O, Aaron spent time as the CMO of Powered Inc. (now part of Sprinklr), VP of social media at online community provider, Mzinga, and as director of digital marketing at Fidelity Investments. Aaron is the co-author of Location Based Marketing for Dummies (Wiley) and current host of the award-winning The Real Chemistry Podcast (formerly What2Know) (iTunes) which features industry leaders talking about innovation and best practices.

You may also like

Join our community and never miss
your favorite episodes

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners